Bioventus has partnered with MTF Biologics to co-develop a placental tissue product for the treatment of painful musculoskeletal conditions, focusing initially on knee osteoarthritis.
Three things to know:
1. The collaboration hopes to develop a solution for knee osteoarthritis that provides symptom relief and delays progression of the disease.
2. Bioventus is an orthobiologics company that creates cost effective solutions for bone healing, bone graft and osteoarthritis.
3. MTF Biologics — also known as the Musculoskeletal Transplant Foundation — is a nonprofit tissue bank governed by a board of surgeons.
"There is a promising and growing body of preclinical and clinical evidence underscoring the potential of these preparations in supporting the body's natural healing processes thanks to the inherent growth factors and regulatory molecules present in placental tissues," said Tony Bihl, CEO of Bioventus.